Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_636_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Puborectalis Muscle
- •Iliococcygeus Muscle
- •Pubococcygeus Muscle
- •Mesorectum
- •Presacral Fascia
- •Retrosacral Fascia
- •Waldeyer’s Fascia
- •Denonvilliers’ Fascia
- •Lateral Ligaments
- •Anorectal Spaces
- •Perianal Space
- •Intersphincteric Space
- •Submucous Space
- •Ischioanal/Ischiorectal Space
- •Supralevator Space
- •Anal Canal Epithelium
- •Internal Anal Sphincter
- •Conjoined Longitudinal Muscle
- •External Anal Sphincter
- •Perineal Body
- •Pelvic Floor Muscles
- •Retrorectal Space
- •Rectal Blood Supply
- •Superior Rectal Artery
- •Middle Rectal Artery
- •Inferior Rectal Artery
- •Cecum
- •The Appendix
- •Ascending Colon
- •Transverse Colon
- •Descending Colon
- •Sigmoid Colon
- •Rectosigmoid Junction
- •Blood Supply
- •Superior Mesenteric Artery
- •Inferior Mesenteric Artery
- •Venous Drainage
- •Lymphatic Drainage
- •Nervous Innervation
- •Embryology
- •Non-rotation
- •Malrotation
- •Reversed Rotation
- •Omphalocele
- •Internal Hernias
- •Proximal Colon Duplication
- •Meckel’s Diverticulum
- •Hirschsprung’s Disease
- •Anorectal Malformations
- •Anal Stenosis
- •Membranous Atresia
- •Anal Agenesis
- •Anorectal Agenesis
- •Rectal Atresia or “High Atresia”
- •Persistent Cloaca
- •2: Colonic Physiology
- •Colonic Anatomy
- •Introduction
- •Colonic Wall Anatomy
- •Colonic Epithelial Cell Types
- •Colonic Flora
- •Electrolyte Regulation and Water Absorption
- •Short-Chain Fatty Acid Absorption
- •Secretory Role of the Colonic Epithelium
- •Regulation of Electrolyte and Water Absorption and Secretion
- •Colonic Innervation
- •Colonic Motility
- •Cellular Basis of Motility
- •Motility Patterns and Measurement
- •Introduction
- •Normal Continence
- •Rectal Capacity
- •Structural Considerations
- •Normal Defecation
- •Obstructed Defecation
- •Functional Anorectal Pain
- •4: Endoscopy
- •Introduction
- •The Complete Anorectal Examination
- •Patient Position
- •Prone Jackknife
- •Left Lateral
- •Digital Rectal Examination
- •Anoscopy/Proctoscopy
- •Anoscopy
- •Proctoscopy
- •Flexible Endoscopy
- •Flexible Endoscopic Insertion Techniques
- •Torque
- •Dithering/Jiggle
- •Slide-By
- •Special Considerations
- •The Patient Requiring Antibiotics
- •The Anticoagulated Patient
- •Incomplete Colonoscopy
- •Procedure
- •The Endoscopy Suite
- •Instruments
- •Sedation
- •Nitrous Oxide
- •Ketamine
- •Propofol
- •Colonoscopy Technique
- •Anal Intubation
- •Sigmoid Colon
- •Sigmoid-Descending Junction
- •Descending Colon
- •Splenic Flexure
- •Transverse Colon
- •Hepatic Flexure
- •Cecum
- •Patient Position
- •Abdominal Pressure
- •Sigmoidoscopy
- •Colonoscopy
- •Bowel Preparation
- •Ileocecal Valve Intubation
- •Terminal Ileum
- •Alternate Techniques
- •Chromocolonoscopy (Chromoendoscopy)
- •Full-Spectrum Endoscopy
- •Complications
- •Sedation Complications
- •Vasovagal/Cardiac Arrhythmia
- •Pulmonary
- •Procedural Complications
- •Splenic Injury
- •Perforation
- •Post-polypectomy Syndrome
- •Bleeding
- •Infectious Complications
- •Simulation
- •Documentation
- •Quality
- •PillCam Endoscopy
- •Introduction
- •Polypectomy Techniques
- •Endoscopic Mucosal Resection
- •Endoscopic Submucosal Dissection
- •Combined Endo-Laparoscopic Surgery (CELS)
- •Major Abdominal Surgery
- •Anorectal Surgery
- •Preoperative Testing
- •Laboratory Studies
- •Electrocardiogram
- •Chest X-ray
- •Initial Workup
- •Who Needs Additional Testing?
- •Preoperative “Optimization”
- •Coronary Stent Management
- •AICD/Pacemaker Management
- •COPD
- •Obstructive Sleep Apnea (OSA)
- •Diabetes
- •Obesity
- •Malnutrition
- •Solid Organ Transplant Recipients
- •Substance Abuse
- •Alcohol
- •Tobacco
- •Opioids
- •Medications
- •Anticoagulation
- •Immunosuppressive Agents
- •Chemotherapy
- •Introduction
- •Preoperative Management
- •Patient Education
- •Intraoperative Pathway
- •Minimally Invasive Colorectal Surgery
- •Intraoperative Fluid Administration
- •Analgesia
- •Venous Thromboembolism (VTE) Prophylaxis
- •Postoperative Recovery
- •Analgesia
- •Intravenous Fluid Management
- •Venous Thromboembolism (VTE) Prophylaxis
- •Quality Pathway Evaluation Measures
- •Quality Improvement Measures
- •8: Postoperative Complications
- •Introduction
- •Ureteral Injury
- •Bladder Injury
- •Urethral Injury
- •IV Fluid Management
- •Wound Management
- •Bladder Management
- •Pain Management
- •Academic Medical Center
- •Wound Complications
- •Preoperative Considerations
- •Perioperative Interventions
- •Long-Term Complications
- •Genitourinary Complications
- •Fertility Complications
- •Bowel Dysfunction
- •9: Anastomotic Construction
- •Introduction
- •Surgical Staplers
- •Handsewn Anastomoses
- •Compression Anastomoses
- •Tension
- •Blood Supply
- •Prophylactic Drainage
- •Diversion
- •High-Risk Anastomoses
- •Abdominal Anastomoses
- •Small Bowel Anastomoses
- •Ileocolic Anastomoses
- •Pelvic Anastomoses
- •Stapled Colorectal Anastomoses
- •Handsewn Colorectal Anastomosis
- •Ileorectal Anastomosis
- •Neorectal Reservoirs
- •Handsewn Coloanal Anastomosis
- •Unanticipated Pelvic Anastomosis
- •Inadequate Colonic Length
- •Intraoperative Anastomotic Failure
- •10: Anastomotic Complications
- •Anastomotic Leak
- •Overview
- •Consequences
- •Prevention
- •Diagnosis
- •Treatment
- •Anastomotic Stricture
- •Anastomotic Bleeding
- •Introduction
- •Patient History
- •Levator Syndrome
- •Physical Examination
- •Abdominal Examination
- •Inguinal Examination
- •Digital Rectal Examination
- •Conclusion
- •12: Hemorrhoids
- •Anatomy
- •Etiology
- •Epidemiology
- •Clinical Presentation
- •History
- •Physical Examination
- •Treatment
- •Medical Management
- •Dietary
- •Topical Therapies
- •Oral Therapy
- •Rubber Band Ligation
- •Infrared Photocoagulation
- •Sclerotherapy
- •Excisional Hemorrhoidectomy-Closed Technique
- •Excisional Hemorrhoidectomy Open Technique (Milligan-Morgan)
- •Excisional Hemorrhoidectomy (Circumferential or Whitehead)
- •Urinary Retention
- •Postoperative Hemorrhage
- •Anal Stenosis
- •Postoperative Infection
- •Fecal Incontinence
- •Stapled Hemorrhoidopexy
- •Transanal Hemorrhoidal Dearterialization
- •Special Clinical Scenarios
- •Thrombosed External Hemorrhoid
- •Pregnancy
- •Crohn’s Disease
- •Immunocompromised Patients
- •13: Anal Fissure
- •Pathogenesis
- •Non-operative Treatment
- •Healing Rates in Acute Anal Fissure
- •Healing Rates in Chronic Anal Fissure
- •Topical
- •Nitroglycerin
- •Calcium Channel Blockers
- •Botulinum Toxin Type A
- •Operative Treatment
- •Anal Dilation
- •Anal Sphincterotomy (Technique)
- •Outcomes Between Closed and Open Anal Sphincterotomy
- •Extent of Sphincterotomy
- •Fissurectomy
- •Results of Sphincterotomy
- •Fissures Without Anal Hypertonicity
- •Crohn’s Disease
- •Conclusions
- •Pathophysiology
- •Anatomy
- •Etiology
- •Evaluation
- •Physical Examination
- •Imaging
- •Computed Tomography (CT)
- •Magnetic Resonance Imaging (MRI)
- •Endoanal Ultrasound (EAUS)
- •Transperineal Sonography (TP-US)
- •Treatment
- •Catheter Drainage
- •Postoperative Management
- •Complications
- •Immediate Postoperative Period
- •Misdiagnosis
- •Special Considerations
- •Necrotizing Anorectal Infection (Fournier’s Gangrene)
- •Diagnosis
- •Treatment
- •Outcomes
- •Anal Fistula
- •Etiology
- •Diagnosis
- •Fistulography
- •Endoanal Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Lay-Open Technique (Fistulotomy)
- •Setons
- •Advancement Flap
- •Technique
- •Technique
- •Fibrin Glue
- •Technique
- •Anal Fistula Plug
- •Technique
- •Novel Techniques
- •15: Complex Anorectal Fistulas
- •Introduction
- •Complex or Recurrent Cryptoglandular Fistulas
- •Surgical Treatment
- •Seton
- •Anal Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Outcomes
- •Seton
- •Advancement Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Rectourethral Fistulas
- •Surgical Treatment
- •Transanal Approach
- •Posterior Approach
- •Transperineal Approach
- •Transabdominal Approach
- •Outcome
- •Postoperative Fistulas
- •Surgical Treatment
- •Outcome
- •16: Rectovaginal Fistula
- •Obstetric Injury
- •Cryptoglandular Disease
- •Crohn’s Disease
- •Endorectal Repairs
- •Transperineal Repairs
- •Tissue Transposition Repairs
- •Martius Flap
- •Gracilis Muscle Transposition
- •Transvaginal Repairs
- •Transabdominal Repair
- •Alternate Repairs
- •Background
- •Etiology
- •Clinical Presentation/Diagnosis
- •Treatment
- •Non-operative Management
- •Operative/Excisional Management
- •Basic Procedures
- •Complex Procedures
- •Karydakis Flap
- •Cleft Lift Procedure (See Video 17.1)
- •Rhomboid/Limberg Flap (See Video 17.2)
- •Disease Recurrence
- •Hidradenitis Suppurativa
- •Etiology/Presentation/Diagnosis
- •Treatment
- •Medical Therapy
- •Surgical/Excisional Therapy
- •Introduction
- •Irritants
- •Steroid-Inducing Itching
- •Infectious
- •Dermatologic
- •Neoplasms
- •Anorectal Conditions
- •Systemic Diseases
- •Physical Examination
- •Infectious
- •Dermatologic
- •Neoplasms
- •Biochemical Testing
- •Microbiology Testing
- •Patch Testing
- •Anoscopy: Proctoscopy
- •Biopsy
- •Evidence-Based Management
- •Primary Prutitis Ani
- •Secondary Prutitis Ani
- •Infectious
- •Dermatologic
- •Systemic Diseases
- •19: Sexually Transmitted Infections
- •Introduction
- •Perianal or Genital Lesions
- •Proctitis
- •Proctocolitis
- •Enteritis
- •Gonorrhea
- •Epidemiology
- •Clinical Presentation
- •Emerging Antibiotic Resistance
- •Chlamydia
- •Epidemiology
- •Clinical Presentation
- •Lymphogranuloma Venereum
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Syphilis
- •Epidemiology
- •Clinical Presentation
- •Testing Recommendations
- •Treatment
- •Chancroid
- •Granuloma Inguinale aka Donovanosis
- •Herpes
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Human Papillomavirus
- •Epidemiology
- •Clinical Presentation
- •Testing
- •Treatment
- •Vaccine
- •Epidemiology
- •Testing
- •Anorectal Issues
- •Molluscum Contagiosum
- •Pubic Lice: Phthirus pubis
- •Scabies
- •20: Anal Intraepithelial Neoplasia
- •Introduction
- •Symptoms
- •Epidemiology
- •Screening/Surveillance
- •Diagnosis
- •Treatment
- •Management Strategies
- •Progression
- •Prevention
- •21: Anal Cancer
- •Anal Squamous Cell Carcinoma
- •Anal Melanoma
- •Anal Adenocarcinoma
- •22: Presacral Tumors
- •General Considerations
- •Anatomic Considerations
- •Diagnosis
- •Management
- •Outcomes
- •Chromosomal Instability
- •Microsatellite Instability
- •CpG Island Methylator Phenotype (CIMP)
- •Adenomatous Polyposis Syndromes
- •Familial Adenomatous Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •FAP Extracolonic Manifestations
- •Management
- •Screening
- •Treatment
- •Colorectal
- •Duodenal Adenomas
- •Desmoid Disease
- •Thyroid Neoplasia
- •MUTYH-Associated Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Extracolonic Cancer Risk
- •Management
- •Screening
- •Treatment
- •Polymerase Proofreading-Associated Polyposis
- •Hamartomatous Polyposis Syndromes
- •Juvenile Polyposis Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Screening
- •Treatment
- •Peutz-Jeghers Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Surveillance
- •Polypectomy
- •Surgery
- •PTEN Hamartoma Tumor Syndrome (PHTS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk Management
- •Serrated Polyposis Syndrome (SPS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Management
- •Screening
- •Treatment
- •Lynch Syndrome
- •Genotype-Phenotype Correlations
- •Muir-Torre Syndrome (MTS)
- •Turcot’s Syndrome
- •Colorectal Cancer Risk
- •Other LS-Associated Cancer Risk
- •Diagnosis
- •Individual Whose Family Meets Amsterdam Criteria but Does Not Have Any Clinical Phenotype
- •Clinical Management
- •Screening
- •Introduction
- •Recommended Screening Guidelines
- •Screening Cessation
- •Colonoscopy
- •Incomplete Colonoscopy
- •Complications
- •CT Colonography (CTC) or Virtual Colonoscopy
- •Flexible Sigmoidoscopy
- •Complications
- •Fecal Occult Blood Testing (FOBT)/Fecal Immunochemical Testing (FIT)
- •Stool DNA Testing
- •Double-Contrast Barium Enema (DCBE)
- •Surveillance
- •History
- •Adenoma
- •Hamartomas Polyps
- •Early Cancer (T1) Within Polyp
- •Chemoprevention
- •Background
- •Clinical Presentation
- •Preoperative Evaluation
- •Tumor Localization
- •Total Colon Evaluation
- •Carcinoembryonic Antigen (CEA)
- •Radiographic Evaluation
- •Lymph Node Evaluation
- •Lynch Syndrome Phenotype
- •26: The Surgical Management of Colon Cancer
- •Preoperative Preparation
- •Physiologic Assessment
- •Tumor Localization
- •Surgical Technique
- •Extent of Resection
- •Mesocolic Resection
- •Right Colectomy
- •Open Approach
- •Lateral-to-Medial Approach
- •Posterior (Inferior-to-Superior) Approach
- •Superior to Inferior Approach
- •Medial-to-Lateral Approach
- •Anastomosis
- •Laparoscopic Approach
- •Medial-to-Lateral Approach
- •Posterior (Inferior-to-Superior) Approach
- •Left Colectomy
- •Open
- •Anastomotic Assessment
- •Hand-Assisted Medial-to-Lateral Approach
- •Subtotal Colectomy
- •Open Approach
- •Laparoscopic Approach
- •Total Abdominal Colectomy with Ileorectal Anastomosis
- •Special Circumstances
- •Laparoscopy
- •Obstructing Colon Cancers
- •Perforated Colon Cancers
- •Management of Primary Colon Cancer in the Setting of Distant Metastasis
- •Outcomes for Colon Cancer
- •Short-Term Outcomes
- •Long-Term Outcomes
- •Introduction
- •Total Colon Evaluation
- •Locoregional Imaging
- •Computed Tomography
- •Endorectal Ultrasound
- •T Staging
- •N Staging
- •Magnetic Resonance
- •Whole-Body Imaging
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •28: Rectal Cancer: Neoadjuvant Therapy
- •Introduction
- •Historical Context
- •Postoperative Radiotherapy
- •Preoperative Radiotherapy
- •Radiosensitizing Agents
- •Preoperative Versus Postoperative Radiation
- •Short- Versus Long-Course Preoperative Radiotherapy
- •Choosing Optimal Treatment Regimens
- •The European Approach
- •Selected Adjuvant Systemic Chemotherapy
- •Selective Nonoperative Management
- •Techniques
- •Results
- •Lymphovascular Invasion
- •Tumor Budding
- •Introduction
- •Neoadjuvant Chemoradiotherapy
- •31: Proctectomy
- •Pathological Assessment
- •Preoperative Preparation
- •Operative Approaches
- •Open Low Anterior Resection (LAR)
- •Laparoscopic Low Anterior Resection
- •Robotic Low Anterior Resection
- •Abdominoperineal Resection (APR)
- •Extralevator or “Cylindrical” APR
- •Special Considerations
- •Distal Margin
- •Coloanal Anastomosis
- •Fecal Diversion
- •Extended Resection
- •Intraoperative Radiation Therapy
- •Flap Closure Following Abdominoperineal Resection
- •Functional Outcomes
- •Oncologic Outcomes
- •Multidisciplinary Rectal Cancer Care
- •32: Rectal Cancer Decision-Making
- •Assessment
- •Early Rectal Neoplasms
- •Local Excision
- •Endoscopically Excised Malignant Polyps
- •Surgical Considerations
- •Intraoperative Decisions
- •Midrectal Cancers
- •Low Rectal Cancers
- •Low Hartmann Resection Versus APR
- •Special Situations
- •Obstructing Rectal Cancer
- •Perforated Rectal Cancer
- •Synchronous Hepatic Metastases
- •33: Colorectal Cancer: Postoperative Adjuvant Therapy
- •Colon Cancer
- •Stage III Colon Cancer
- •Stage II Colon Cancer
- •Rectal Cancer
- •Patients Who Did Not Undergo Neoadjuvant Therapy
- •Patients Who Underwent Neoadjuvant Radiotherapy/Chemoradiotherapy
- •Patients Undergoing Local Excision
- •34: Colorectal Cancer: Surveillance After Curative-Intent Therapy
- •Introduction
- •Physical Examination
- •Laboratory Testing
- •Abdominal Imaging
- •Chest Imaging
- •Colonoscopy
- •Stage 1 Disease
- •Cost
- •Introduction
- •Determining Resectability
- •Multimodal Therapy Including Intraoperative Radiation
- •General Considerations
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Recurrences that Extend Anteriorly
- •Resection that Includes Sacrectomy
- •Stage I: Anterior Component
- •Stage II: Posterior Component
- •Stage III: Spinal Reconstructive Component
- •Soft Tissue Reconstruction
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Sacropelvic Resections
- •Palliative Approach
- •Introduction
- •Diagnostic Strategies
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •Magnetic Resonance Imaging
- •Contrast-Enhanced Ultrasound
- •Biopsy
- •Multidisciplinary Evaluation
- •Surgical Emergency
- •Self-Expanding Intraluminal Metal Stents
- •Liver-First Strategy
- •Colon-First Strategy
- •Margin Status
- •Other Liver Metastasis Strategies: Hepatic Intra-arterial Chemotherapy/Chemoembolization
- •Pulmonary Metastasis
- •Peritoneal Metastasis
- •Ovarian Metastases
- •Bone
- •Brain
- •Pancreas
- •Adrenal
- •Retroperitoneal Lymph Nodes
- •37: Appendiceal Neoplasms
- •Introduction
- •Epidemiology
- •Epithelial Neoplasms
- •Neuroendocrine Appendiceal Lesions/Carcinoid Tumors
- •Goblet Cell Carcinoids
- •Clinical Features
- •Diagnostic Procedures
- •Medical Management
- •Appendectomy
- •Right Hemicolectomy

Pilonidal Disease andHidradenitis
Suppurativa
EricK.Johnson
17
Key Concepts
• Pilonidal disease presents with a wide range
of symptoms, and multiple treatment options
exist. Treatment should be tailored to the
severity of disease, anatomy of disease, and
patient expectations.
• Because of the wide array of available surgical options, the surgeon treating pilonidal
disease should master 3–4 approaches that
are applicable to a wide range of disease
presentations.
• Treatments applied to both pilonidal disease
and hidradenitis suppurativa should not be
more disabling for the patient than the disease
itself.
• There are numerous medical options available
to treat hidradenitis suppurativa. They should
be investigated and attempted prior to aggressive radical surgical management.
• Radical excision of hidradenitis suppurativa
with surgical reconstruction offers the best
hope to avoid disease recurrence.
Electronic Supplementary Material The online
version of this chapter (https://doi.org/10.1007/978-3-
030-01165-9_17) contains supplementary material,
which is available to authorized users.
E. K. Johnson (*)
Department of Colorectal Surgery, Cleveland Clinic,
Cleveland, OH, USA
Background
The term “pilonidal” is derived from the root
words “pilus” (a hair) and “nidus” (nest).
Etiology
• There has been considerable debate over
whether PD is congenital or acquired, but
most would currently agree that it is an
acquired disease.
• It is generally believed that the initiating event
is traumatization of the skin and surrounding
hair follicles in the natal cleft.
• This occurs secondary to trapping of hairs, not
necessarily those arising locally in the natal
cleft.
• The local anatomy creates an unfavorable
environment where friction, warmth, moisture,
and perhaps local hypoxia lead to local trauma
secondary to the barbed texture of the hair.
• A granulomatous foreign body-type reaction
results.
• There is even some histological and immunohistochemical evidence that PD may represent a unilocalized type of hidradenitis
suppurativa.
• Disease typically begins as a small sinus that
may drain uid but then can progress to
numerous sinuses with associated cystic dilation and potential abscess formation.
© ASCRS (American Society of Colon and Rectal Surgeons) 2019
S. R. Steele et al. (eds.), The ASCRS Manual of Colon and Rectal Surgery,
https://doi.org/10.1007/978-3-030-01165-9_17
233

234
• In some cases, unless the process is interrupted, it can become more widespread leading to worsening symptoms.
• Disease can range from the asymptomatic
single sinus found incidentally up to a severe
locally destructive process associated with
signicant disability.
• PD is not limited to the natal cleft area, and
there are several reports of disease occurring
in the interdigital areas in hair dressers and the
umbilicus.
• Affect males more commonly than females,
at 1.9 and 1.7 per 1000 person-years
respectively.
• Several risk factors that have been implicated
in the development of PD include positive
family history of disease, elevated body mass
index (BMI > 25), poor hygiene, hirsutism,
deep natal cleft anatomy, occupation that
requires prolonged sitting, and excessive
sweating.
• A positive family history may not only predispose to disease occurrence but may also be
associated with increased recurrence rates
after surgery as well as earlier onset of
disease.
E. K. Johnson
Fig. 17.1 This image shows a hirsute individual with
midline “pits” that could go unnoticed. Note the poor
hygiene
a
b
Clinical Presentation/Diagnosis
• Commonly encountered presentations:
– Acute pilonidal abscess that requires
drainage
– Ofce visit to discuss denitive surgical
therapy after either acute abscess drainage
or persistent disease of moderate severity
• Simple history taking and a physical exam
will in most cases solidify the diagnosis.
– Patients will often complain of pain over
the sacrococcygeal area with drainage of
clear uid or bleeding.
– Physical exam will reveal “pits” in the mid-
line. There may be one or several pits
(Fig.17.1).
– In more signicant cases, there may be
open wounds that can have a large range in
size (Fig17.2a–c).
– Acute abscess is typically associated with
overlying erythema, uctuance, and severe
local tenderness (Fig.17.3).
c
Fig. 17.2 (a–c) These images show a range of open
wounds that may be seen with pilonidal disease

17 Pilonidal Disease andHidradenitis Suppurativa
Fig. 17.3 This image depicts an acute pilonidal abscess
235
• Recurrent disease in the patient who has
already undergone surgical excision is another
commonly encountered scenario (Fig.17.4).
– Early recurrence is often actually persis-
tence of an open wound that never healed
after surgery, non-healing midline sacrococcygeal wound.
– Recurrence presents similarly to primary
PD and may be related to poor surgical
technique, patient non-compliance, or
failure to modify the pre-existing risk factors that led to disease in the rst place.
Treatment
• Treatment should be tailored to the patient’s
expectations, disease anatomy, and disease
severity.
• Options range from non-operative therapies
up to wide local excision with local ap
reconstruction.
• The debate of open wound management versus closed management remains.
Non-operative Management
• If the patient is asymptomatic, and physical
examination reveals no concerning ndings,
they require no operative management.
Fig. 17.4 This image shows a patient who developed
recurrence after an attempt at a cleft lift procedure.
Incorrect performance of the distal portion of the procedure may have led to this recurrence
• Risk factor modication such as weight loss,
avoidance of prolonged sitting at work,
improved hygiene, and weekly clipping of
hair in and adjacent to the natal cleft may
reduce the chance that a patient will develop
symptoms related to PD.
• Laser hair removal has been advocated as a
long-lasting alternative for the conservative
management of PD that may reduce recurrence rates.
– Treatments are performed over 3–11 ses-
sions at 6–8-week intervals and can be
quite costly.
• Although not necessarily considered nonoperative (maybe non-excisional) therapy,
methods employing the use of phenol or brin
glue injection to ablate sinus tracts have been
investigated in small series.
– The potential advantages of these thera-
pies over excisional methods are more
rapid recovery and less post-procedural
pain.

236
E. K. Johnson
– These techniques often employ tract curet-
tage, debridement, and hair removal, which
contribute signicantly to success.
– Use of phenol as an ablative agent has been
associated with success rates of 60–95%.
– Fibrin glue injection combined with a vari-
ety of techniques has shown success in the
range of 90–100%.
– A video-assisted ablative technique has
also been described using a 4 mm rigid
hysteroscope with a 5 French working for
irrigation and hair removal, and the cavity
and tracts are ablated using a bipolar
electrode.
Operative/Excisional Management
• There are numerous methods available for the
operative management of PD.
• Essentially, it is possible to nd evidence to
support whatever procedure one prefers to
perform.
Basic Procedures
1. Laying open of the cyst and all sinus tracts:
“unroong” of disease.
• Often, unroong was combined with mar-
supialization of the wound.
• Recurrence rates of 15–35%.
2. Wide local excision of all disease down to the
post-sacral fascia.
• Higher volume of excised specimen is
associated with a higher surgical site infection rate and likely a higher risk of recurrent disease.
3. Simple tract unroong and curettage are particularly helpful in the setting of minor disease affecting the perianal area (often mistaken
as an anal stula).
• It is important to ensure that as much of the
surgical wound as possible be kept off the
midline, as midline wounds tend to have
some difculty with healing (Fig.17.5a–c).
4. Primary closure has been combined with
drainage in some settings with a wide variation in results.
• The use of a drain has not been shown to
result in improved results as far as patient
satisfaction, healing, or infection.
• A recent randomized controlled trial com-
paring the laying open method to wide
excision with primary closure showed that
healing occurred faster in the primary closure group with no differences in the
groups noted at 1year of follow-up.
5. Primary closure augmented by the placement
of gentamicin-impregnated collagen in the
abc
Fig. 17.5 (a–c) These images show yet another patient
who presented with what was thought to be an anal stula.
Midline pits were noted, and the disease was treated with
a lay-open technique, which resulted in rapid healing. Of
note, this could potentially represent hidradenitis
suppurativa

17 Pilonidal Disease andHidradenitis Suppurativa
base of the wound with overlying tissue
closure.
• The results showed improved healing at
4weeks, improved postoperative pain, and
lower cost in the primary closure group.
• Recurrence rates were no different at
5years.
6. Primary closure with hydrogen peroxide irrigation or wide local excision with hydrogen
peroxide irrigation.
• The wide local excision combined with
peroxide irrigation group showed the lowest recurrence rate and the fastest time to
healing.
• The investigators attributed this to the abil-
ity to clearly delineate all tracts and disease
with peroxide irrigation, allowing them to
perform a more precise and low-volume
excision.
7. “Pit picking” procedures.
• Relatively minor in terms of the amount of
tissue excised, they result in small wounds
and may be ideal for those suffering with
mild-to-moderate levels of disease.
• The basic premise of this method is that the
central pits are excised with minimal surrounding tissue, hair and debris are
removed, the old adjacent abscess cavity or
“cyst” is excised through a lateral incision
using an undermining technique, the pit
excision sites are closed primarily, and the
lateral incision is closed partially to allow
for drainage (Fig.17.6).
• This results in a good cosmetic result with
minimal pain, early return to work, and
rapid healing.
Complex Procedures
• The common thread among all “complex”
procedures is the mobilization of adjacent tissue to achieve primary wound closure – in
effect, the creation of a local ap.
• Some of these procedures combine wide local
excision of diseased tissue with ap reconstruction, while others preserve as much local
tissue as possible.
• Include the Karydakis ap, the Bascom cleft
lift procedure, the rhomboid or Limberg ap
237
Fig. 17.6 This image shows a patient 2 weeks after a
simple Bascom or “pit picking” operation
procedure, Z-plasty, V-Y advancement ap,
and other rotational ap techniques.
• It is possible that these procedures are more
effective in curing disease, because they result
in a attening of the natal cleft anatomy.
Karydakis Flap
• Excision of the affected tissue in the midline,
typically leaving an elliptical defect.
• A beveled skin ap is then created and mobilized across the midline to facilitate a primary closure that is lateral of midline
(Fig.17.7).
• A closed suction drain may be used or
omitted.
• The purported advantages of this procedure
are the tension free closure that is out of the
midline coupled with some attening of the
natal cleft.
• Has been shown to be superior to simple primary midline closure in terms of patient satisfaction, recurrence rate, and rate of
postoperative complications.

238
ab
cd
Fig. 17.7 This drawing depicts one method of performing a Karydakis ap
Cleft Lift Procedure (See Video 17.1)
Bascom cleft lift
• This is a simple but intricate procedure that is
designed to “lift” the natal cleft and results in
an incision that is closed off the midline.
• Interestingly, wide excision is not required. In
fact, the only tissue that is excised is the overlying skin on one side of the natal cleft.
• This procedure requires that the patient be
marked prior to incision to establish a “safe
zone,” beyond which no dissection is
performed.
• Outcomes reveal excellent healing rates (97%)
and low recurrence rates (2.5%).
• There is little question that this technique is
easier to perform, takes less time, and removes
Fig. 17.8 This image shows the planned lines of incision
for the rhomboid ap. Note that the caudal tip is not
located directly over the anus. This modication results in
a wound that does not come to a point at the location of
highest risk
less tissue than the more complex ap procedures such as the rhomboid ap.
• It results in attening of the natal cleft, which
is likely desirable.
• Unfortunately, not every patient with PD is a
candidate for this procedure; those with complex recurrent disease and large open wounds
and disease that is very close to the anus may
not be ideal candidates and may require more
extensive ap procedures.
of PD but is typically reserved for more severe
cases.
• The procedure involves a “diamond”- or
rhombus-shaped area of wide excision encompassing all disease in the midline (Fig.17.8).
• One must ensure that the thickness of the
mobilized lipocutaneous ap approximates
the thickness of the tissue that is excised.
• This technique works particularly well in the
setting of complex recurrent disease.
Rhomboid/Limberg Flap (See Video 17.2)
• The rhomboid ap is a useful but more complex procedure that can be used in any setting
• In some cases, the disease spans a very large
area over the sacrum extending from the perianal area for a long distance cephalad.
E. K. Johnson

17 Pilonidal Disease andHidradenitis Suppurativa
239
– When this is the case, the technique can
still be used but may be modied.
– The most difcult area in which to achieve
healing is the caudal midline.
– An excision can be performed, and ap
created such that the caudal midline is covered leaving an open wound cephalad
(Fig.17.9).
– The remaining wound can be managed in a
variety of ways, but the use of a negative
pressure wound therapy device makes this
management easy (Fig.17.10a, b).
• Potential surgical site-related postoperative
complications include wound dehiscence, ap
necrosis, hematoma, wound infection, and
seroma (4%, 0–2%, 1%, 3–5%, and 3%,
respectively).
• Recurrence can be seen in approximately 4%.
• The evidence indicates that the LF or MLF is
associated with faster return to work, lower
rates of surgical site infection, lower recurrence, and lower rates of wound dehiscence.
Disease Recurrence
• Familial history of disease, increased sinus
number, larger cavity diameter, and primary
wound closure have been shown to be associated with higher rates of recurrence.
Recurrence has been shown to be lower in
those that undergo surgical incision and drainage prior to denitive surgery as compared to
those who have spontaneous abscess rupture.
• Surgery performed in the “after-hours” and
potentially emergent setting has been associated with higher recurrence rates.
• Recurrences up to 20years after surgery are
seen, so studies investigating long-term outcomes should have at least 5 years of
follow-up.
Hidradenitis Suppurativa
• The disease is a chronic inammatory disorder involving the skin of apocrine gland-bearing areas, typically the perineum, inguinal,
inframammary, and axillary regions.
• Individuals aficted with HS suffer a tremendous impact upon their quality of life with
effects on both their physical and mental
health.
• The prevalence of HS is estimated to be 127.8
per 100,000 or 0.13%, with a higher prevalence among women.
• This translates to fewer than 200,000 affected
patients in the United States.
• The reported mean age of onset is between 20
and 24 years of age, with less than 8% of
affected individuals developing disease earlier
than 13years of age.
• Early-onset disease seems to be correlated
with family history of disease.
Fig. 17.9 This image shows a patient with recurrent disease that resulted in a large abscess that was drained superiorly and required some tissue debridement. This resulted
in a large area of disease to be addressed
Etiology/Presentation/Diagnosis
• It was once thought purely to be secondary to
infection of the apocrine sweat glands, but
there is now general agreement that this is not
true.

240
E. K. Johnson
ab
Fig. 17.10 (a, b) This image shows a patient similar to that in Fig.17.9. The ap was created and closed leaving an
open wound superiorly that was treated with negative pressure wound therapy and healed easily
• The disease is characterized by chronic follicular occlusion resulting in secondary
inammation of the apocrine glands.
• The initial inciting event is believed to be
hyperkeratosis that leads to follicular
occlusion.
• Others have proposed that the follicular occlusion occurs as a result of a defect in the follicular support system.
• In any case, there is ultimate dysfunction in
the entire folliculopilosebaceous unit (FPSU)
that leads to follicular rupture and secondary
bacterial infection involving the apocrine
glands.
• Disease manifests initially as open comedones, typically with a few “heads,” and tender
subcutaneous papules.
• In many this leads to a chronic and progressive worsening of symptoms in which
additional nodules form, rupture, and drain a
thick mucopurulent foul-smelling liquid. Over
time this leads to sinus tract formation, brotic
subcutaneous scarring, and potentially disabling contractures of the affected limb.
• There are a number of variables that have been
identied as risk factors for disease.
– Tobacco smoking and obesity have been
associated with both the presence of disease and with lower remission rates.
– Weight loss has been shown to be tempo-
rally associated with remission.
– Sweating, shaving, deodorant use, and fric-
tion have also been implicated as potential
exacerbating factors.
– It is also believed that there may be dietary
triggers that worsen disease (high carbohydrate diet, milk consumption).
• Diagnosis is typically made based on common
physical exam ndings including skin thickening, induration, abscess formation, the presence of draining sinuses, and contractures in
the regions of the body considered at risk.
• There are several other diagnoses in the differential that should be considered
(Table17.1).
• There have been two classication or staging
systems proposed to grade disease, the Hurley
system and the Sartorius system (Tables 17.2
and 17.3).
• French group have introduced a latent classication system, which better groups HS
patients into three distinct phenotypes
(Table17.4).
• Hurley system seems to be most useful to physicians making treatment recommendations
for affected individuals.
• There is a well-established link between HS
and acne, pilonidal disease, inammatory

17 Pilonidal Disease andHidradenitis Suppurativa
241
Table 17.1 A list of diagnoses that should be considered
in the differential diagnosis of hidradenitis suppurative
Diseases to be considered in the differential diagnosis
Acne
Actinomycosis
Anal stula
Carbuncles
Cat scratch disease
Cellulitis
Crohn’s disease
Cutaneous blastomycosis
Dermoid cyst
Granuloma inguinale
Erysipelas
Furuncles
Inamed epidermoid cyst
Lymphadenopathy
Lymphogranuloma venereum
Nocardia infection
Noduloulcerative syphilis
Perirectal abscess
Pilonidal disease
Tuberculous abscess
Tularemia
Table 17.2 Description of the Hurley classication of
hidradenitis suppurativa, likely the most useful in the clinical setting
Hurley staging system of hidradenitis suppurativa
Stage I Abscess formation, single or multiple,
Stage II Recurrent abscesses with tract formation
Stage III Multiple interconnected tracts and
Table 17.3 The Sartorius scoring or staging system.
Some have modied the system by adding value to the
presence of pain, drainage, or odor. This may be a more
useful system in the research setting to quantify severity
of disease
Sartorius staging system/Sartorius score
Involvement in specic body
areas
Nodules 2 points for each
Fistulas 4 points
Scars 1 point
Other ndings 1 point
Longest distance between two
lesions
If lesions are separated by
normal skin
without scarring or sinus tracts
and scarring, single or multiple, with
widely separated lesions
abscesses throughout an entire region
3 points for each
area involved
2–4 points
Yes-0 points, no-6
points
Table 17.4 Latent or phenotypic classication proposed
by Canoui-Poitrine etal.
Latent
classication Phenotype Affected region
LC1 Axillary-
mammary
LC2 Follicular Ears, chest, back,
LC3 Gluteal Gluteal fold
Axilla, breast,
perineum, inguinal
legs, axillary, breast
bowel disease (particularly Crohn’s disease),
spondyloarthropathy, genetic keratin disorders, and squamous cell carcinoma.
Treatment
• The best way to achieve the lowest recurrence
rate is to aggressively remove all apocrine
gland-bearing tissue in the affected area,
which will often require a complex reconstructive approach.
Medical Therapy
• It appears that treatment is most successful
when used in combined fashion as opposed to
monotherapy.
• Forms of medical therapy include antibacterial washes, topical antibiotics, systemic antibiotics, topical and systemic retinoids,
antiandrogens, intralesional and systemic corticosteroids, immunosuppressives, and oral
metformin.
• While bacterial infection may be a secondary
event in HS, it is clear from published research
that persistence of bacterial colonization,
likely in the form of biolms, plays some role
in the progression of disease.
• Retinoids are likely benecial secondary to
their effect on normalization of epithelial cell
proliferation and differentiation, which in turn
may reduce the occurrence of follicular
occlusion.
• Evidence to support the use of antiandrogen
therapy (estrogen/progestin combinations, nasteride, spironolactone) is fairly weak.
• Other treatment options include tumor necrosis alpha (TNF alpha) inhibitors (iniximab),
photodynamic therapy, intense pulsed light
therapy, and lasers.

242
ab
cd
E. K. Johnson
Surgical/Excisional Therapy
• Excisional therapy is based on the premise
that wide excision of all apocrine gland-bearing tissue in the affected region is the best
method to sustain low recurrence rates.
• All affected skin and subcutaneous fat are
excised down to the fascial level.
• This will often result in a very large defect that
cannot be addressed through simple primary
closure.
– Local ap closure or split thickness skin
grafting (Fig.17.11) are commonly necessary to achieve adequate tissue coverage of
the wound.
– This may require the involvement of a plas-
tic surgeon.
• Attempts at simple unroong of sinus tracts
seem to be associated with higher rates of
recurrence.
• A technique referred to as STEEP (skin tissuesparing excision with electrosurgical peeling)
has been proposed as a “tissue sparing” option
that leads to faster healing with improved
outcomes.
• Vacuum-assisted closure devices can also be
helpful in wounds that are too large to close
primarily, but may not require more complex
reconstructive options.
• In cases where skin grafting may be used, a
two-stage approach has been described. It can
potentially lead to improved outcomes.
Fig. 17.11 (a–d) This series of images shows a patient with Hurley stage III disease who underwent radical excision
and closure with split thickness skin grafting
Соседние файлы в папке Библиотека им академика М.И. Перельмана
